Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-25 MCGIRR DAVID W J Director Grant or award · Stock Option +22,500 65,780
2019-06-25 Royston Aaron Director Grant or award · Stock Option +22,500 22,500
2019-06-25 BERNS PAUL L Director Grant or award · Stock Option +22,500 65,780
2019-06-25 Whitcup Scott M Director Grant or award · Stock Option +22,500 134,099
2019-06-25 Ebel Ted Director Grant or award · Stock Option +22,500 53,423
2019-06-25 MCGIRR DAVID W J Director Grant or award · Stock Option +22,500 65,780
2019-06-25 Sandoval Elisabeth Director Grant or award · Stock Option +11,645 45,000
2019-06-17 Krasnow Ronald A. Grant or award · Stock Option +130,000 130,000
2019-03-19 Sandoval Elisabeth Director Grant or award · Stock Option +33,355 33,355
2019-01-14 Whitcup Scott M Director Exercise or conversion · Stock Option −25,000 $1.83 $46K 77,043
2018-12-10 Spellman Mary Chief Medical Officer Grant or award · Stock Option +96,000 96,000
2018-12-10 Kwon Paul Chief Scientific Officer Grant or award · Stock Option +64,000 64,000
2018-12-10 BALL KRISTINE M SVP, Corporate Strategy & CFO Grant or award · Stock Option +96,000 96,000
2018-07-24 Presidio Partners 2007 GP, L.P. Former 10% Owner Sale −487,500 $7.65 $3.7M 1,907,568
2018-07-24 Presidio Partners 2007 GP, L.P. Former 10% Owner Sale −12,500 $7.65 $96K 48,910
2018-05-03 Kwon Paul Chief Medical Officer Grant or award · Stock Option +64,000 252,512
2018-05-03 BALL KRISTINE M Grant or award · Stock Option +64,000 237,123
2018-05-03 Basta Steven L Chief Executive Officer Grant or award · Stock Option +212,850 669,400
2018-03-02 Presidio Partners 2007 GP, L.P. 10% owner Other acquisition +152,062 152,062
2018-01-29 FMR LLC Conversion +813,478 813,478

Page 19 of 22 · 425 trades